HealthLeaders Media November 16, 2018
The Health and Human Services Secretary has launched a string of ambitious and aggressive initiatives, but he’s also careful not to get too far in front of President Donald Trump.
KEY TAKEAWAYS
Azar comments on social determinants are ‘piggybacking on an industry discussion.’
The HHS secretary is a pragmatist who knows he has to act on reducing drug costs.
Hospital consolidation and its effects on rising care costs may have to be addressed in 2019.
It’s been another interesting week of pronouncements from Health and Human Services Secretary Alex Azar.
In the past month, Azar has called for mandatory transparency in drug pricing, floated the idea of linking Medicare Part B drug prices to...